These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3768254)

  • 41. Comparison of two new controlled-release theophylline formulations in the management of asthma in children and reliability of salivary theophylline concentration.
    Boner AL; Bennati D; Miglioranzi P; Gaburro D
    J Asthma; 1986; 23(4):195-202. PubMed ID: 3531149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of nifedipine and theophylline in asthma.
    Garty M; Cohen E; Mazar A; Ilfeld DN; Spitzer S; Rosenfeld JB
    Clin Pharmacol Ther; 1986 Aug; 40(2):195-8. PubMed ID: 3731682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.
    Lamont H; Pauwels R; Van der Straeten M
    Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
    Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained-release theophylline preparations in asthmatic children. A short-term comparison of two products and the relationship of serum theophylline levels and pulmonary function changes.
    Rachelefsky G; Rohr A; Katz R; Wo J; Gracey V; Spector S; Siegel S; Mickey MR
    Am J Dis Child; 1986 Apr; 140(4):336-40. PubMed ID: 3513540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.
    Weinberger M
    Ann Allergy; 1986 Jan; 56(1):2-12. PubMed ID: 3511775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma theophylline concentrations and airway function in asthmatic children receiving standard and modified RTC therapy.
    Arakawa H; Morikawa A; Shigeta M; Kato M; Kuroume T; Kimura T; Tateno K
    J Asthma; 1992; 29(4):235-43. PubMed ID: 1634448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salivary theophylline estimation in the management of asthma in children.
    Lena SM; Hutchins P; Wood CB; Turner P
    Postgrad Med J; 1980 Feb; 56(652):85-7. PubMed ID: 7393801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ
    Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods of comparing pharmacokinetics of slow release preparations: a comparison of "Theo-Dur" and "Phyllocontin" in patients with asthma.
    Jackson SH; Shah K; Turner P
    Eur J Clin Pharmacol; 1986; 30(3):313-7. PubMed ID: 3732367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison between steady state pharmacokinetics and effects of two once-daily, slow-release theophylline formulations in nocturnal asthma.
    Nielsen NH; Madsen F; Svendsen UG; Almind M; Frølund L; Weeke B
    Pulm Pharmacol; 1988; 1(2):77-84. PubMed ID: 2980291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Twice daily slow-release theophylline vs placebo for 'morning-dipping' in asthma.
    Davies PD; Fennerty AG; Benfield GF; Parrish RW; Campbell IA
    Br J Clin Pharmacol; 1984 Mar; 17(3):335-40. PubMed ID: 6324835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Slow-release theophyllines: serum and saliva levels in asthmatic children].
    Souto Martínez I; Duque Hernández J; Galván Tudela L; Alvarez Sanz E; Díaz Gómez MI
    An Esp Pediatr; 1988 Jun; 28(6):513-6. PubMed ID: 3195854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S; Vrabec B; Francetić I; Bakran I
    Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation.
    Bülow KB; Larsson H; Leideman T
    Eur J Clin Pharmacol; 1975 Feb; 8(2):115-8. PubMed ID: 1233207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.